109 related articles for article (PubMed ID: 11900811)
1. Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats.
Kitamura Y; Araki H; Suemaru K; Gomita Y
Pharmacol Biochem Behav; 2002 May; 72(1-2):397-402. PubMed ID: 11900811
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
[TBL] [Abstract][Full Text] [Related]
3. Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats.
Kawakami Y; Kitamura Y; Araki H; Kitagawa K; Suemaru K; Shibata K; Gomita Y
Pharmacol Biochem Behav; 2005 May; 81(1):65-70. PubMed ID: 15894065
[TBL] [Abstract][Full Text] [Related]
4. Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment-resistant depression: involvement of 5-HT(2A) receptors?
Kitamura Y; Akiyama K; Kitagawa K; Shibata K; Kawasaki H; Suemaru K; Araki H; Sendo T; Gomita Y
Pharmacol Biochem Behav; 2008 May; 89(3):235-40. PubMed ID: 18255130
[TBL] [Abstract][Full Text] [Related]
5. Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
Kitamura Y; Shibata K; Akiyama K; Kimoto S; Fujitani Y; Kitagawa K; Kanzaki H; Ouchida M; Shimizu K; Kawasaki H; Sendo T; Gomita Y
J Pharmacol Sci; 2008 Jan; 106(1):100-6. PubMed ID: 18187923
[TBL] [Abstract][Full Text] [Related]
6. Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors.
Kuroda Y; Mikuni M; Ogawa T; Takahashi K
Psychopharmacology (Berl); 1992; 108(1-2):27-32. PubMed ID: 1384079
[TBL] [Abstract][Full Text] [Related]
7. The Influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats.
Umeda Y; Amano M; Suemaru K; Yamaguchi T; Kitamura Y; Gomita Y; Kawasaki H; Araki H
Acta Med Okayama; 2007 Dec; 61(6):311-7. PubMed ID: 18183075
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.
Kouhata S; Kagaya A; Nakae S; Nakata Y; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):395-407. PubMed ID: 11294484
[TBL] [Abstract][Full Text] [Related]
9. Effects of imipramine and lithium on the suppression of cell proliferation in the dentate gyrus of the hippocampus in adrenocorticotropic hormone-treated rats.
Doi M; Miyazaki I; Nagamachi T; Shinomiya K; Matsunaga H; Sendo T; Kawasaki H; Asanuma M; Gomita Y; Kitamura Y
Acta Med Okayama; 2010 Aug; 64(4):219-23. PubMed ID: 20802538
[TBL] [Abstract][Full Text] [Related]
10. Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats.
Suemaru K; Araki H; Kitamura Y; Yasuda K; Gomita Y
Psychopharmacology (Berl); 2001 Dec; 159(1):38-41. PubMed ID: 11797067
[TBL] [Abstract][Full Text] [Related]
11. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
Gorzalka BB; Hill MN; Sun JC
Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
[TBL] [Abstract][Full Text] [Related]
12. Effect of lithium carbonate on the enhancement of serotonin 2A receptor elicited by dexamethasone.
Jitsuiki H; Kagaya A; Goto S; Horiguchi J; Yamawaki S
Neuropsychobiology; 2000 Jan; 41(2):55-61. PubMed ID: 10644925
[TBL] [Abstract][Full Text] [Related]
13. Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment.
Nabeshima T; Yamaguchi K; Yoshida S; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1986 May; 24(5):1275-9. PubMed ID: 3725829
[TBL] [Abstract][Full Text] [Related]
14. Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.
Kitamura Y; Fujitani Y; Kitagawa K; Miyazaki T; Sagara H; Kawasaki H; Shibata K; Sendo T; Gomita Y
Biol Pharm Bull; 2008 Feb; 31(2):246-9. PubMed ID: 18239281
[TBL] [Abstract][Full Text] [Related]
15. [Interaction of 5-HT and HPA axis in depression and treatment-resistant depression].
Kitamura Y; Araki H; Gomita Y
Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):319-25. PubMed ID: 12089903
[TBL] [Abstract][Full Text] [Related]
16. Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat.
Mørk A
Eur Neuropsychopharmacol; 1998 Dec; 8(4):267-72. PubMed ID: 9928915
[TBL] [Abstract][Full Text] [Related]
17. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test.
Kitamura Y; Araki H; Gomita Y
Pharmacol Biochem Behav; 2002; 71(1-2):63-9. PubMed ID: 11812508
[TBL] [Abstract][Full Text] [Related]
18. Modulation of serotonin2A receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine.
Katagiri H; Kagaya A; Nakae S; Morinobu S; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1269-81. PubMed ID: 11474845
[TBL] [Abstract][Full Text] [Related]
19. A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation.
Dave KD; Harvey JA; Aloyo VJ
Pharmacol Biochem Behav; 2002 May; 72(1-2):371-8. PubMed ID: 11900808
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with imipramine and lithium increases cell proliferation in the hippocampus in adrenocorticotropic hormone-treated rats.
Kitamura Y; Doi M; Kuwatsuka K; Onoue Y; Miyazaki I; Shinomiya K; Koyama T; Sendo T; Kawasaki H; Asanuma M; Gomita Y
Biol Pharm Bull; 2011; 34(1):77-81. PubMed ID: 21212521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
